A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This vital tumor protector protein is frequently disabled in several types of tumors, causing https://throbsocial.com/story24116072/nanobodies-restore-p53-the-potential-hope-for-tumor-therapy